MedTrace Logo

Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study

NCT02296632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2015-08-19

No results posted yet for this study

Summary

This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The investigators' overarching hypothesis is that if patients have better and more timely information about whether Enbrel is working, then they will become more empowered and engaged in their treatment, more curious about how it may - or may not - be working, and potentially more compliant with therapy. However, this hypothesis remains largely untested.

Conditions

  • Arthritis, Rheumatoid
  • Medication Adherence

Interventions

BEHAVIORAL

Motion sensors and daily online assessments

Patients will be asked to wear motion sensors during their waking hours and complete daily Patient Reported Outcomes online assessments.

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Brennan Spiegel, MD, MSHS · Cedars-Sinai Medical Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02296632 on ClinicalTrials.gov